Replies to post #102 on Neoleukin Therapeutics Inc (NLTX)

[mick]

Neoleukin Therapeutics Announces Preclinical Data for NL-201 at American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/13/2022 02:00:00 PM
Mizuho Securities Sticks to Their Buy Rating for Neoleukin Therapeutics (NLTX) • TipRanks • 04/11/2022 02:25:10 AM